Cevian Capital II GP Limited via Aurora Nominees Limited and UBS AG has increased its voting rights in Smith & Nephew plc from 13.21% to 14.01% as of July 22, 2026. Smith & Nephew plc is a medical technology company that develops and manufactures products for orthopaedics, orthopaedics, sports medicine, and wound management.
